• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Labcorp, Quest, and ARUP Develop Bird Flu Tests with CDC Help

Labcorp, Quest, and ARUP Develop Bird Flu Tests with CDC Help

by Ron Shinkman | Jan 28, 2025 | Clinical Diagnostics Insider, Testing Trends-dtet

The assays were developed with the CDC as part of recent trend of public-private partnerships to improve pandemic preparedness

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Dx Deals: New Premerger Regulations Could Slow Down Pace of Transactions

Dx Deals: New Premerger Regulations Could Slow Down Pace of Transactions

by Ron Shinkman | Nov 27, 2024 | Deals-lir, Essential, Lab Industry Advisor

The new rules, which were approved by the FTC in October and will go into effect in mid-January, aim to put a damper on consolidation

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Dx Deals: More than $62 Million Invested in Startup Labs in Recent Weeks

Dx Deals: More than $62 Million Invested in Startup Labs in Recent Weeks

by Ron Shinkman | Oct 1, 2024 | Deals-lir, Essential, Lab Industry Advisor

The rounds of funding to Clarapath, PreciseDx, and Precision Epigenomics come at a time when other M&A activity is seasonally slow

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Dx Deals: Quest Makes Big North American Expansion with LifeLabs Acquisition

Dx Deals: Quest Makes Big North American Expansion with LifeLabs Acquisition

by Ron Shinkman | Aug 30, 2024 | Deals-lir, Essential, Lab Industry Advisor

The roughly $1 billion deal will boost the company’s annual revenue by about 7 percent, and will give Quest a stronger presence in Canada

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Dx Deals: Outreach Deals by Quest, Labcorp Are Still Ramping Up

Dx Deals: Outreach Deals by Quest, Labcorp Are Still Ramping Up

by Ron Shinkman | Jul 24, 2024 | Deals-lir, Essential, Lab Industry Advisor

Though the two national players have closed dozens of such deals over the past decade, much runway for new transactions apparently remains

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com